Trial
NCT02776891
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Lymphoma, Large B-Cell, Diffuse
Intervention
Gallium citrate
Why stopped
Unexpected dose production issues prevented study start up
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-10